Form 4 Tracker
David Patience

Chief Financial Officer · 2 filings · Latest: May 15, 2026

TriSalus Life Sciences, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
TLSI
David PatienceChief Financial OfficerMay 15, 2026
Purchase
$2.437,100$17.3K275,757
TLSI
David PatienceChief Financial OfficerFeb 23, 2026
Purchase
$4.103,657$15.0K268,657